Guido Ferrari

Assistant Professor, Surgery

School of Medicine

(919) 684-2862

gflmp@duke.edu

Visit Website

Summary

Dr. Ferrari is currently an Associate Research Professor in the Department of Surgery, Division of Surgical Sciences at Duke University Medical Center. He is directing the ELISPOT, CTL, and ADCC laboratories for the HVTN central laboratory at Duke. He has been serving as a WHO/UNAIDS Vaccine Initiative consultant for the past six years, and coordinated the organization of 5 international workshops for the transfer of ELISpot and ICS technologies to new laboratory sites involved in HIV vaccine studies.

Topics

Infectious diseases

Locations

South Africa

Projects

Infectious Diseases in Africa: Measurement of Immune Responses

South Africa

Recent Publications

Pardi, N, LaBranche, CC, Ferrari, G, Cain, DW, Tombácz, I, Parks, RJ, Muramatsu, H, Mui, BL, Tam, YK, Karikó, K, Polacino, P, Barbosa, CJ, Madden, TD, Hope, MJ, Haynes, BF, Montefiori, DC, Hu, S-L, & Weissman, D. (2019, April). Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. Molecular Therapy. Nucleic Acids, 15, 36-47.

Pollara, J, Jones, DI, Huffman, T, Edwards, RW, Dennis, M, Li, SH, Jha, S, Goodman, D, Kumar, A, LaBranche, CC, Montefiori, DC, Fouda, GG, Hope, TJ, Tomaras, GD, Staats, HF, Ferrari, G, & Permar, SR. (2019, March 6). Bridging vaccine-induced HIV-1 neutralizing and effector antibody responses in rabbit and rhesus macaque animal models. Journal of Virology,.

Curtis, AD, Walter, KA, Nabi, R, Jensen, K, Dwivedi, A, Pollara, J, Ferrari, G, Van Rompay, KKA, Amara, RR, Kozlowski, PA, & De Paris, K. (2019, March). Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques. Aids Research and Human Retroviruses, 35 (3), 310-325.

Dennis, M, Eudailey, J, Pollara, J, McMillan, AS, Cronin, KD, Saha, PT, Curtis, AD, Hudgens, MG, Fouda, GG, Ferrari, G, Alam, M, Van Rompay, KKA, De Paris, K, Permar, S, & Shen, X. (2019, March). Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques. Journal of Virology, 93 (5).

Asbach, B, Kibler, KV, Köstler, J, Perdiguero, B, Yates, NL, Stanfield-Oakley, S, Tomaras, GD, Kao, S-F, Foulds, KE, Roederer, M, Seaman, MS, Montefiori, DC, Parks, R, Ferrari, G, Forthal, DN, Phogat, S, Tartaglia, J, Barnett, SW, Self, SG, Gottardo, R, Cristillo, AD, Weiss, DE, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Jacobs, BL, Pantaleo, G, & Wagner, R. (2019, February). Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.

Kibler, KV, Asbach, B, Perdiguero, B, García-Arriaza, J, Yates, NL, Parks, R, Stanfield-Oakley, S, Ferrari, G, Montefiori, DC, Tomaras, GD, Roederer, M, Foulds, KE, Forthal, DN, Seaman, MS, Self, S, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, S, Cristillo, AD, Weiss, D, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Wagner, R, Pantaleo, G, & Jacobs, BL. (2019, February). Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC. Journal of Virology, 93 (3).

Pantaleo, G, Janes, H, Karuna, S, Grant, S, Ouedraogo, L, Allen, M, Tomaras, GD, Frahm, N, Montefiori, DC, Ferrari, G, Ding, S, Lee, C, Robb, ML, Esteban, M, Wagner, R, Alexandre-Bart, P, Rettby, N, McElrath, MJ, Gilbert, PB, Kublin, J, Corey, L, & Trials Network, NIAIDHIVV. (2019, January 25). Co-Administration of HIV Env Protein with DNA and/or NYVAC Vaccines in Humans Results in Earlier and Potent Generation of Anti-Env Antibody Responses..

Spearman, P, Tomaras, GD, Montefiori, DC, Huang, Y, Elizaga, ML, Ferrari, G, Alam, SM, Isaacs, A, Ahmed, H, Hural, J, McElrath, MJ, Ouedraogo, L, Pensiero, M, Butler, C, Kalams, SA, Overton, ET, Barnett, SW, HVTN 088 Protocol Team, , & NIH/NIAID HIV Vaccine Trials Network, . (2019, January 7). Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest. The Journal of Infectious Diseases,.

van Eeden, C, Wibmer, CK, Scheepers, C, Richardson, SI, Nonyane, M, Lambson, B, Mkhize, NN, Vijayakumar, B, Sheng, Z, Stanfield-Oakley, S, Bhiman, JN, Bekker, V, Hermanus, T, Mabvakure, B, Ismail, A, Moody, MA, Wiehe, K, Garrett, N, Karim, SA, Dirr, H, Fernandes, MA, Sayed, Y, Shapiro, L, Ferrari, G, Haynes, BF, Moore, PL, & Morris, L. (2018, December). V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity. Cell Reports, 25 (11), 3123-3135.e6.

Himes, JE, Goswami, R, Mangan, RJ, Kumar, A, Jeffries, TL, Eudailey, JA, Heimsath, H, Nguyen, QN, Pollara, J, LaBranche, C, Chen, M, Vandergrift, NA, Peacock, JW, Schiro, F, Midkiff, C, Ferrari, G, Montefiori, DC, Hernandez, XA, Aye, PP, & Permar, SR. (2018, November). Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys. Mucosal Immunology, 11 (6), 1716-1726.

View All Publications

Guido Ferrari

Summary

Topics

Locations

Projects

Infectious Diseases in Africa: Measurement of Immune Responses

Recent Publications

Related News

DGHI Research Roundup: March 2017

DGHI Research Roundup: January 2017

DGHI Research Roundup: November 2016